Document is current
Any future updates will be listed below
-
Authors
Watson, Oliver J. https://orcid.org/0000-0003-2374-0741
Tran, Thu Nguyen-Anh
Zupko, Robert J. https://orcid.org/0000-0001-8757-483X
Symons, Tasmin https://orcid.org/0000-0003-2565-701X
Thomson, Rebecca
Visser, Theodoor
Rumisha, Susan
Dzianach, Paulina A. https://orcid.org/0000-0003-4202-9680
Hathaway, Nicholas
Kim, Isaac https://orcid.org/0000-0002-9737-8100
Juliano, Jonathan J. https://orcid.org/0000-0002-0591-0850
Bailey, Jeffrey A. https://orcid.org/0000-0002-6899-8204
Slater, Hannah https://orcid.org/0000-0003-4291-7899
Okell, Lucy https://orcid.org/0000-0001-7202-6873
Gething, Peter
Ghani, Azra https://orcid.org/0000-0002-0007-4910
Boni, Maciej F. https://orcid.org/0000-0002-0830-9630
Parr, Jonathan B. https://orcid.org/0000-0002-4465-9830
Cunningham, Jane https://orcid.org/0000-0002-2758-4822
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 19 August 2025
First Online: 6 October 2025
Competing interests
: O.J.W., R.Z. and T.N.-A.T. have received personal consultancy fees from the WHO related to pfhrp2/3 modeling. J.B.P. reports research support from the WHO related to pfhrp2/3 deletion molecular surveillance and, outside the scope of this paper, research support from Gilead Sciences, nonfinancial support from Abbott Laboratories and consulting fees for Zymeron Corporation. The other authors declare no competing interests.
